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Background:  Treatment of acute decompensated heart failure (ADHF) with loop diuretics is complicated by insufficient natriuresis. We hypothesize 
that insufficient natriuretic response to diuretic therapy, characterized by a lower amount of sodium excreted in response to furosemide (estimated 
by spot urine sodium-to-furosemide ratio [USFR]), predicts subsequent worsening renal function (WRF) and adverse long-term clinical events.
Methods:  We enrolled 41 subjects treated with continuous intravenous furosemide infusion and measured spot USFR ≥3 hours after a steady 
level of furosemide was achieved. WRF was defined as serum creatinine (sCr) rise of ≥0.3 mg/dL. Adverse long-term events (death, transplant or 
rehospitalization) were tracked for 4±3 months.
Results:  In our study cohort (age 60±15 years, admission sCr 1.8±0.9 mg/dL, median BNP 674 pg/mL, furosemide dose 13±6 mg/hour), baseline 
USFR did not correlate with age, BNP, sCr or diuretic dose (p>0.40 all). Low USFR predicted subsequent WRF, and independent of admission sCr, 
diabetes mellitus and hypertension (OR: 3.5, 95% CI: 1.3-12.3,p=0.009). USFR ≤2.3 mmol/mg detected WRF with 78% sensitivity, 63% specificity 
(AUC 0.74, p=0.013) and was associated with poorer long-term outcomes (HR: 2.8, 95% CI 1.2-7.6, p=0.024).
Conclusions:  In ADHF patients treated with continuous furosemide infusion, insufficient natriuretic responses to diuretic therapy predict 
subsequent WRF and adverse long-term events independent of baseline renal function.
